Essential cybersecurity considerations when selecting a security solution
By Scott Thomas This is part three of a series on how to plan, build, and assemble a robust security system for your cannabis business. In part one, we focused on video management systems. In part two, access control. This article focuses on cybersecurity considerations. When it comes to... Read more
New York State agencies haven’t touched millions sitting in medical marijuana funds
An NYCI investigation has found that two New York State agencies are sitting on millions of dollars collected from medical marijuana taxes, but neither has spent the money — despite a mandate that the funds be used for public health and safety initiatives. As of Feb. 28, the Office of... Read more
New York Cannabis “Gifting” — Criminal!

New York continues to crack down on unlicensed cannabis sales masquerading as “gifts” or “membership fees.” The Office of Cannabis Management (OCM) sent cease and desist letters a few weeks ago, which threatened substantial fines, possible criminal penalties, and “put[ting] your ability to obtain a license in the legal cannabis market at substantial risk.” Of

The post New York Cannabis “Gifting” — Criminal! appeared first on Harris Bricken Sliwoski LLP.

Read more
Bloomios Begins Trading on OTCQB Venture Market as BLMS, as Hemp-Derived Cannabinoid Product Sales Exceed $8 million
Ryan Allway March 15th, 2022 News, Top News SANTA BARBARA, Calif., March 15, 2022 /PRNewswire/ — Bloomios, Inc. (OTCQB: BLMS), a leading researcher, manufacturer and wholesaler of hemp-derived cannabinoid nutraceuticals and cosmetics, will begin trading on the OTCQB® Venture Market under the symbol, BLMS, at the opening of the market today. (PRNewsfoto/Bloomios, Inc.)... Read more
TILT Amends Purchase and Sale Agreement for its Taunton, Massachusetts Facility
Ryan Allway March 15th, 2022 News, Top News PHOENIX, March 15, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO:TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, has signed an amendment (the “Amendment”) to its... Read more
Nova Mentis Announces Closing of Non-Brokered Financing
Ryan Allway March 15th, 2022 Psychedelics, Top News VANCOUVER, BC, March 15, 2022 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders, is pleased to announce that it has completed a non-brokered private... Read more
A Connecticut legislative committee on Monday discussed a bill that would set the state up to provide certain patients with access to psychedelic-assisted treatment with substances like MDMA and psilocybin. Former top military officials, advocates and scientists testified in favor of the proposal. The joint Public Health Committee took... Read more
A Connecticut legislative committee on Monday discussed a bill that would set the state up to provide certain patients with access to psychedelic-assisted treatment with substances like MDMA and psilocybin. Former top military officials, advocates and scientists testified in favor of the proposal. The joint Public Health Committee took... Read more
A Connecticut legislative committee on Monday discussed a bill that would set the state up to provide certain patients with access to psychedelic-assisted treatment with substances like MDMA and psilocybin. Former top military officials, advocates and scientists testified in favor of the proposal. The joint Public Health Committee took... Read more
Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

Wesana Health reports positive feedback from FDA on pre-IND meeting regarding development of SANA -013 and is anticipating commencing a clinical trial in Q4 2022.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )